Atea Pharmaceuticals
AVIR
AVIR
103 hedge funds and large institutions have $158M invested in Atea Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
16% less capital invested
Capital invested by funds: $189M → $158M (-$30.4M)
48% less call options, than puts
Call options by funds: $23K | Put options by funds: $44K
Holders
103
Holding in Top 10
1
Calls
$23K
Puts
$44K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$617K | |
| 3 | +$598K | |
| 4 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$369K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$328K |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$1.22M | |
| 3 | -$815K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$588K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$369K |
